Pharming (PHAR) Exchange Rate Effect (2020 - 2025)
Pharming's (PHAR) quarterly Exchange Rate Effect came in at $1.2 million in Q4 2025, up 155.93% YoY from $482548.2 in Q4 2024, and up 155.93% on a QoQ basis from -$2.2 million in Q4 2024.
Pharming (PHAR) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Pharming (PHAR) has 6 years of Exchange Rate Effect data on file, last reported at $1.2 million in Q4 2025.
- Quarterly Exchange Rate Effect rose 155.93% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.4 million (up 36.45% YoY) and the FY2025 annual result came in at $7.9 million, up 458.11% from the prior year.
- Exchange Rate Effect improved to $1.2 million in Q4 2025, from -$2.2 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.4 million in Q3 2021 to a low of -$11.7 million in Q3 2022.
- A 5-year average of -$1.1 million and a median of -$122500.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect slumped 4498.65% — and 2022, when it surged 162.31%.
- Tracing PHAR's Exchange Rate Effect over 5 years: stood at -$650000.0 in 2021, then surged by 162.31% to $405000.0 in 2022, then climbed by 8.4% to $439000.0 in 2023, then sank by 602.96% to -$2.2 million in 2024, then surged by 155.93% to $1.2 million in 2025.
- The last three Exchange Rate Effect figures came in at $1.2 million (Q4 2025), -$2.2 million (Q4 2024), and $439000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | -913,000.00 |
| Sep 30, 2023 | -913,000.00 |
| Dec 31, 2022 | 405,000.00 |
| Dec 31, 2022 | 405,000.00 |
| Sep 30, 2022 | -11.66 Mn |
| Sep 30, 2022 | -11.66 Mn |
| Dec 31, 2021 | -650,000.00 |
| Dec 31, 2021 | -650,000.00 |
| Sep 30, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.40 Mn |
| Dec 31, 2020 | -14,134.60 |
| Dec 31, 2020 | -14,134.60 |
| Sep 30, 2020 | -11.60 Mn |
| Sep 30, 2020 | -11.60 Mn |